Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-6

Memory B cell–guided extended interval dosing of ocrelizumab in multiple sclerosis

Delania Meng, Rosaria Sacco, Giulio Disanto [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-10

Bayesian optimal interval design for dose finding in drug-combination trials

Ruitao Lin, Guosheng Yin

Statistical Methods in Medical Research

Retricted access

Research article

First published 2024-2

Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activity

Nicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-6

Extended interval dosing with ocrelizumab in multiple sclerosis

Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-09

A Survey of Extended-Interval Aminoglycoside Dosing Practices in United States Adult Cystic Fibrosis Programs

William A Prescott

Respiratory Care

Free access

Research article

First published 2012-10

Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: minimizing side-effects without affecting weight gain and food intake

Manon W H Schaap, Joost J Uilenreef, Manuela D Mitsogiannis [...]

Laboratory Animals

Retricted access

Research article

First published 2021-4

Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab

Chiara Rosa Mancinelli, Cristina Scarpazza, Cinzia Cordioli [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-11

No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab

Magnus Johnsson, Helen H Farman, Kaj Blennow [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-3

Probability intervals of toxicity and efficacy design for dose-finding clinical trials in oncology

Xiaolei Lin, Yuan Ji

Statistical Methods in Medical Research

Open access

Research article

First published 2024-2

Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis

Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk [...]

Multiple Sclerosis Journal

Search results